LymphedemaV1, Main, Exploration, bibRecord, 003F09

Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.

Identifieur interne : 003F09 ( Main/Exploration ); précédent : 003F08; suivant : 003F10

Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.

Auteurs : Suphet Tuipae [Thaïlande] ; Marut Yanaranop ; Noppadol Oniem

Source :

Journal of the Medical Association of Thailand = Chotmaihet thangphaet [ 0125-2208 ] ; 2012.

RBID : pubmed:22619897

Descripteurs français

KwdFr :
- Adulte d'âge moyen, Adénocarcinome (), Adénocarcinome (anatomopathologie), Adénocarcinome (mortalité), Adénocarcinome (radiothérapie), Carcinome épidermoïde (), Carcinome épidermoïde (anatomopathologie), Carcinome épidermoïde (mortalité), Carcinome épidermoïde (radiothérapie), Facteurs de risque, Femelle, Humains, Hystérectomie, Mâle, Radiothérapie adjuvante, Tumeurs du col de l'utérus (), Tumeurs du col de l'utérus (anatomopathologie), Tumeurs du col de l'utérus (mortalité), Tumeurs du col de l'utérus (radiothérapie).
MESH :
- anatomopathologie : Adénocarcinome, Carcinome épidermoïde, Tumeurs du col de l'utérus.
- mortalité : Adénocarcinome, Carcinome épidermoïde, Tumeurs du col de l'utérus.
- radiothérapie : Adénocarcinome, Carcinome épidermoïde, Tumeurs du col de l'utérus.
- Adulte d'âge moyen, Adénocarcinome, Carcinome épidermoïde, Facteurs de risque, Femelle, Humains, Hystérectomie, Mâle, Radiothérapie adjuvante, Tumeurs du col de l'utérus.

English descriptors

KwdEn :
- Adenocarcinoma (mortality), Adenocarcinoma (pathology), Adenocarcinoma (radiotherapy), Adenocarcinoma (surgery), Carcinoma, Squamous Cell (mortality), Carcinoma, Squamous Cell (pathology), Carcinoma, Squamous Cell (radiotherapy), Carcinoma, Squamous Cell (surgery), Female, Humans, Hysterectomy, Male, Middle Aged, Radiotherapy, Adjuvant, Risk Factors, Uterine Cervical Neoplasms (mortality), Uterine Cervical Neoplasms (pathology), Uterine Cervical Neoplasms (radiotherapy), Uterine Cervical Neoplasms (surgery).
MESH :
- mortality : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- pathology : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- radiotherapy : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- surgery : Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms.
- Female, Humans, Hysterectomy, Male, Middle Aged, Radiotherapy, Adjuvant, Risk Factors.

Abstract

To assess the benefit of adjuvant radiotherapy after radical hysterectomy in node-negative FIGO stage IB-IIA cervical cancer patients with intermediate risk factors.

PubMed: 22619897

Affiliations:

Thaïlande

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.</title>
<author><name sortKey="Tuipae, Suphet" sort="Tuipae, Suphet" uniqKey="Tuipae S" first="Suphet" last="Tuipae">Suphet Tuipae</name>
<affiliation wicri:level="1"><nlm:affiliation>Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand. suphetgyn@hotmail.com</nlm:affiliation>
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok</wicri:regionArea>
<wicri:noRegion>Bangkok</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yanaranop, Marut" sort="Yanaranop, Marut" uniqKey="Yanaranop M" first="Marut" last="Yanaranop">Marut Yanaranop</name>
</author>
<author><name sortKey="Oniem, Noppadol" sort="Oniem, Noppadol" uniqKey="Oniem N" first="Noppadol" last="Oniem">Noppadol Oniem</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22619897</idno>
<idno type="pmid">22619897</idno>
<idno type="wicri:Area/PubMed/Corpus">002118</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002118</idno>
<idno type="wicri:Area/PubMed/Curation">002118</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002118</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002118</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002118</idno>
<idno type="wicri:Area/Ncbi/Merge">004D99</idno>
<idno type="wicri:Area/Ncbi/Curation">004D99</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004D99</idno>
<idno type="wicri:doubleKey">0125-2208:2012:Tuipae S:role:of:adjuvant</idno>
<idno type="wicri:Area/Main/Merge">003F23</idno>
<idno type="wicri:Area/Main/Curation">003F09</idno>
<idno type="wicri:Area/Main/Exploration">003F09</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.</title>
<author><name sortKey="Tuipae, Suphet" sort="Tuipae, Suphet" uniqKey="Tuipae S" first="Suphet" last="Tuipae">Suphet Tuipae</name>
<affiliation wicri:level="1"><nlm:affiliation>Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand. suphetgyn@hotmail.com</nlm:affiliation>
<country xml:lang="fr">Thaïlande</country>
<wicri:regionArea>Gynecologic Oncology Unit, Department of Obstetrics and Gynecology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok</wicri:regionArea>
<wicri:noRegion>Bangkok</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yanaranop, Marut" sort="Yanaranop, Marut" uniqKey="Yanaranop M" first="Marut" last="Yanaranop">Marut Yanaranop</name>
</author>
<author><name sortKey="Oniem, Noppadol" sort="Oniem, Noppadol" uniqKey="Oniem N" first="Noppadol" last="Oniem">Noppadol Oniem</name>
</author>
</analytic>
<series><title level="j">Journal of the Medical Association of Thailand = Chotmaihet thangphaet</title>
<idno type="ISSN">0125-2208</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenocarcinoma (mortality)</term>
<term>Adenocarcinoma (pathology)</term>
<term>Adenocarcinoma (radiotherapy)</term>
<term>Adenocarcinoma (surgery)</term>
<term>Carcinoma, Squamous Cell (mortality)</term>
<term>Carcinoma, Squamous Cell (pathology)</term>
<term>Carcinoma, Squamous Cell (radiotherapy)</term>
<term>Carcinoma, Squamous Cell (surgery)</term>
<term>Female</term>
<term>Humans</term>
<term>Hysterectomy</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Radiotherapy, Adjuvant</term>
<term>Risk Factors</term>
<term>Uterine Cervical Neoplasms (mortality)</term>
<term>Uterine Cervical Neoplasms (pathology)</term>
<term>Uterine Cervical Neoplasms (radiotherapy)</term>
<term>Uterine Cervical Neoplasms (surgery)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Adénocarcinome ()</term>
<term>Adénocarcinome (anatomopathologie)</term>
<term>Adénocarcinome (mortalité)</term>
<term>Adénocarcinome (radiothérapie)</term>
<term>Carcinome épidermoïde ()</term>
<term>Carcinome épidermoïde (anatomopathologie)</term>
<term>Carcinome épidermoïde (mortalité)</term>
<term>Carcinome épidermoïde (radiothérapie)</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hystérectomie</term>
<term>Mâle</term>
<term>Radiothérapie adjuvante</term>
<term>Tumeurs du col de l'utérus ()</term>
<term>Tumeurs du col de l'utérus (anatomopathologie)</term>
<term>Tumeurs du col de l'utérus (mortalité)</term>
<term>Tumeurs du col de l'utérus (radiothérapie)</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Adénocarcinome</term>
<term>Carcinome épidermoïde</term>
<term>Tumeurs du col de l'utérus</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Adenocarcinoma</term>
<term>Carcinoma, Squamous Cell</term>
<term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Adénocarcinome</term>
<term>Carcinome épidermoïde</term>
<term>Tumeurs du col de l'utérus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Adenocarcinoma</term>
<term>Carcinoma, Squamous Cell</term>
<term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Adenocarcinoma</term>
<term>Carcinoma, Squamous Cell</term>
<term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Adénocarcinome</term>
<term>Carcinome épidermoïde</term>
<term>Tumeurs du col de l'utérus</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Adenocarcinoma</term>
<term>Carcinoma, Squamous Cell</term>
<term>Uterine Cervical Neoplasms</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Hysterectomy</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Radiotherapy, Adjuvant</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Adénocarcinome</term>
<term>Carcinome épidermoïde</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hystérectomie</term>
<term>Mâle</term>
<term>Radiothérapie adjuvante</term>
<term>Tumeurs du col de l'utérus</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To assess the benefit of adjuvant radiotherapy after radical hysterectomy in node-negative FIGO stage IB-IIA cervical cancer patients with intermediate risk factors.</div>
</front>
</TEI>
<affiliations><list><country><li>Thaïlande</li>
</country>
</list>
<tree><noCountry><name sortKey="Oniem, Noppadol" sort="Oniem, Noppadol" uniqKey="Oniem N" first="Noppadol" last="Oniem">Noppadol Oniem</name>
<name sortKey="Yanaranop, Marut" sort="Yanaranop, Marut" uniqKey="Yanaranop M" first="Marut" last="Yanaranop">Marut Yanaranop</name>
</noCountry>
<country name="Thaïlande"><noRegion><name sortKey="Tuipae, Suphet" sort="Tuipae, Suphet" uniqKey="Tuipae S" first="Suphet" last="Tuipae">Suphet Tuipae</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003F09 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003F09 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:22619897
   |texte=   Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:22619897" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.

Role of adjuvant radiotherapy after radical hysterectomy in node-negative stage IB-IIA cervical cancer with intermediate risk factors.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.